KRAS and neoplasm: While this hypothesis offers an explanation of why serum vitamin D levels were not associated with PFS in KRAS-mutant patients, it assumes that the major mechanism of action underlying vitamin D’s efficacy is tumor-dependent (as opposed to “host”-dependent).